Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter for Squamous Cell Cancer of the Head and Neck Radiovirotherapy
- 1 March 2012
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 23 (3), 295-301
- https://doi.org/10.1089/hum.2011.128
Abstract
Oncolytic measles virus (MV) encoding the human thyroidal sodium iodide symporter (MV-NIS) has proved to be safe after intraperitoneal or intravenous administration in patients with ovarian cancer or multiple myeloma, respectively, but it has not yet been administered through intratumoral injection in humans. Squamous cell carcinoma (SCC) of the head and neck (SCCHN) usually is locally invasive and spreads to the cervical lymph nodes, which are suitable for the intratumoral administration of oncolytic viruses. To test whether oncolytic MV is an effective treatment for SCCHN, we used oncolytic MV-NIS to infect SCCHN in vitro and in vivo. The data show that SCCHN cells were infected and killed by MV-NIS in vitro. Permissiveness of the tumor cells to MV infection was not affected by irradiation after viral addition. Monitored noninvasively through radioiodine-based single-photon emission computed tomography/computed tomography, intratumorally virus-delivered NIS has concentrated the radioiodine in the MV-NIS–treated tumors in the FaDu mouse xenograft model of human SCCHN, and the antitumor effect could be boosted significantly (p131I. MV-NIS could be a promising new anticancer agent that may substantially enhance the outcomes of standard therapy after intratumoral administration in patients with locally advanced SCCHN.Keywords
This publication has 35 references indexed in Scilit:
- Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancerJournal of Clinical Epidemiology, 2011
- Pinhole micro-SPECT/CT for noninvasive monitoring and quantitation of oncolytic virus dispersion and percent infection in solid tumorsGene Therapy, 2011
- Sodium Iodide Symporter (NIS)-Mediated Radiovirotherapy for Pancreatic CancerAmerican Journal of Roentgenology, 2010
- Oncolytic measles viruses encoding interferon β and the thyroidal sodium iodide symporter gene for mesothelioma virotherapyCancer Gene Therapy, 2010
- Phase I Study of Noninvasive Imaging of Adenovirus-mediated Gene Expression in the Human ProstateMolecular Therapy, 2008
- Efficacy and Safety of the Oncolytic Herpes Simplex Virus rRp450 Alone and Combined With CyclophosphamideMolecular Therapy, 2008
- Preclinical Pharmacology and Toxicology of Intravenous MV-NIS, an Oncolytic Measles Virus Administered With or Without CyclophosphamideClinical Pharmacology & Therapeutics, 2007
- Viruses as anticancer drugsTrends in Pharmacological Sciences, 2007
- Dual Therapy of Ovarian Cancer Using Measles Viruses Expressing Carcinoembryonic Antigen and Sodium Iodide SymporterClinical Cancer Research, 2006